EGFR and neoplasm: Take the PLGA-anti-EGFR nanoparticles employed in this study as an example, there are several situations wherein an effective background reduction method can be especially helpful: 1) tumor is small; 2) tumor targeting is compromised due to previous EGFR-targeting treatments; 3) a considerable number of nanoparticles have been cleared out of the tumor volume.